In addition, MEIS1 was identified to reduce major histocompatibility complex class II (MHCII)expression in acute myeloid leukemia (AML) cells [17]), MEIS1 overexpression improved survival in patients with AML [18]. This evidence concerns the gene MEIS1 and acute myeloid leukemia.